[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  ovtlyr [@ovtlyr](/creator/twitter/ovtlyr) on x XXX followers Created: 2025-07-09 16:02:08 UTC $GILD Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Wednesday that they have completed arrangements to provide a long-acting HIV prevention drug to low-income countries, even though they are not receiving funding from a major U.S. program designed to combat the global HIV/AIDS crisis. XX engagements  **Related Topics** [countries](/topic/countries) [$gild](/topic/$gild) [gilead sciences](/topic/gilead-sciences) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/ovtlyr/status/1942977581466402986)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ovtlyr @ovtlyr on x XXX followers
Created: 2025-07-09 16:02:08 UTC
$GILD Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Wednesday that they have completed arrangements to provide a long-acting HIV prevention drug to low-income countries, even though they are not receiving funding from a major U.S. program designed to combat the global HIV/AIDS crisis.
XX engagements
Related Topics countries $gild gilead sciences stocks healthcare
/post/tweet::1942977581466402986